

Alizé Pharma 3 to present data from its AZP-3404 program at ENDO 2019

PDC*line Pharma enters into licensing agreement with LG Chem to develop PDC*lung cancer vaccine in Asia

Minoryx appoints Didier Le Normand as Group CFO and General Manager of its Belgian subsidiary

Minoryx receives approval from Spanish Agency to initiate phase 2 study in Friedreich’s Ataxia

Pherecydes Pharma reports successful patient treatment with bacteriophages

Minoryx Therapeutics extends its activities in Belgium

Biomunex signs a licensing agreement with Sanofi for the development of bi- and multi-specific antibodies

Minoryx Therapeutics announces early completion of patient randomization in the ADVANCE trial
